Biomind Labs Inc.
BMND
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 359.20K | 347.50K | 439.80K | 675.30K | 897.10K |
| Depreciation & Amortization | 6.60K | 6.60K | 6.60K | 9.20K | 19.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 402.50K | 440.20K | 691.20K | 991.40K | 1.42M |
| Operating Income | -402.50K | -440.20K | -691.20K | -991.40K | -1.42M |
| Income Before Tax | -704.90K | -796.00K | -945.00K | -1.19M | -1.45M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.70 | -0.80 | -0.95 | -1.19 | -1.45 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -704.90K | -796.00K | -945.00K | -1.19M | -1.45M |
| EBIT | -402.50K | -440.20K | -691.20K | -991.40K | -1.42M |
| EBITDA | -394.00K | -423.30K | -674.20K | -972.00K | -1.40M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 301.76M | 299.05M | 299.05M | 299.05M | 299.05M |
| Average Diluted Shares Outstanding | 301.76M | 299.05M | 299.05M | 299.05M | 299.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |